Cluster Information | Plasmid Cluster ID | C1540 |
Reference Plasmid | 1111525849479042_bin.22__k141_102845 | |
Reference Plasmid Size | 253329 | |
Reference Plasmid GC Content | 0.55 | |
Reference Plasmid Mobility Type | non-mobilizable |
mutid | gname | pos | count | tissue | frequnt | biotype | consequence | impact | nucchange | aachange |
---|---|---|---|---|---|---|---|---|---|---|
M0006367 | FCJFCOMK_00110 | 127518 | 6 | Skin | 0.01 | protein_coding | missense_variant | MODERATE | 23A>C | Lys8Thr |
M0006368 | FCJFCOMK_00131 | 152826 | 9 | Skin | 0.02 | protein_coding | missense_variant | MODERATE | 1180C>A | Arg394Ser |
Gene Name | vf_gene_id | vf_name | identity | evalue | qstart | qend | query_coverage | subject_coverage | vf_category | gene_description | condition |
---|
Gene Name | compound | identity | evalue | qstart | qend | query_coverage | subject_coverage | group |
---|---|---|---|---|---|---|---|---|
FCJFCOMK_00063 | Tellurium (Te), Proflavin [class: Acridine] | 80.7 | 2.6e-91 | 5 | 196 | 0.9697 | 0.9746 | experiment |
FCJFCOMK_00112 | Acriflavine [class: Acridine], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Hoechst 33342 [class: Bisbenzimide], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Methyl Viologen [class: Paraquat], Ethidium Bromide [class: Phenanthridine], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)] | 76.3 | 1.4e-197 | 1 | 497 | 1.0000 | 0.9960 | experiment |
FCJFCOMK_00116 | Methyl Viologen [class: Paraquat] | 75.5 | 3.2e-119 | 1 | 273 | 0.9964 | 0.9317 | experiment |
FCJFCOMK_00143 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], Triclosan [class: Phenolic compounds], Methyl Viologen [class: Paraquat], Hydrogen Peroxide (H2O2) [class: Peroxides] | 84.4 | 7.7e-49 | 1 | 122 | 1.0000 | 1.0167 | experiment |
FCJFCOMK_00144 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], Triclosan [class: Phenolic compounds], Methyl Viologen [class: Paraquat], Hydrogen Peroxide (H2O2) [class: Peroxides] | 85.3 | 1.8e-49 | 1 | 109 | 1.0000 | 1.0000 | experiment |
FCJFCOMK_00179 | Cyclohexane [class: Cycloalkane], Diphenyl Ether [class: Phenyl], n-hexane [class: Alkane] | 92.1 | 5.5e-66 | 1 | 126 | 0.9921 | 0.9921 | experiment |
FCJFCOMK_00180 | Cyclohexane [class: Cycloalkane], Diphenyl Ether [class: Phenyl], n-hexane [class: Alkane] | 88.1 | 3.6e-70 | 20 | 162 | 0.8773 | 0.9931 | experiment |
FCJFCOMK_00063 | Tellurium (Te), Proflavin [class: Acridine] | 87 | 1.1e-98 | 5 | 197 | 0.9747 | 0.9797 | prediction |
FCJFCOMK_00112 | Acriflavine [class: Acridine], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Hoechst 33342 [class: Bisbenzimide], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Methyl Viologen [class: Paraquat], Ethidium Bromide [class: Phenanthridine], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)] | 90.7 | 1.8e-235 | 1 | 494 | 0.9940 | 0.9940 | prediction |
FCJFCOMK_00116 | Methyl Viologen [class: Paraquat] | 78.8 | 1.7e-121 | 1 | 274 | 1.0000 | 0.9352 | prediction |
FCJFCOMK_00143 | Spermidine [class: Polyamines] | 100 | 4.5e-58 | 1 | 122 | 1.0000 | 1.0000 | prediction |
FCJFCOMK_00144 | Sodium Deoxycholate (SDC) [class: Acid], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Spermidine [class: Polyamines] | 100 | 1.7e-53 | 1 | 109 | 1.0000 | 1.0000 | prediction |
FCJFCOMK_00179 | Cyclohexane [class: Cycloalkane], Diphenyl Ether [class: Phenyl], n-hexane [class: Alkane] | 100 | 1.8e-70 | 1 | 127 | 1.0000 | 0.9845 | prediction |
FCJFCOMK_00180 | Cyclohexane [class: Cycloalkane], Diphenyl Ether [class: Phenyl], n-hexane [class: Alkane] | 100 | 8e-87 | 1 | 163 | 1.0000 | 1.0000 | prediction |
Gene Name | aro_accession | identity | evalue | qstart | qend | query_coverage | subject_coverage | drug_class | amr_gene_family | resistance_mechanism |
---|---|---|---|---|---|---|---|---|---|---|
FCJFCOMK_00143 | ARO:3004580 | 84.4 | 1.94e-63 | 1 | 122 | 1.0000 | 1.0167 | macrolide antibiotic | small multidrug resistance (SMR) antibiotic efflux pump | antibiotic efflux |
FCJFCOMK_00144 | ARO:3004583 | 85.3 | 2.81e-64 | 1 | 109 | 1.0000 | 1.0000 | macrolide antibiotic | small multidrug resistance (SMR) antibiotic efflux pump | antibiotic efflux |
FCJFCOMK_00179 | ARO:3000263 | 92.1 | 1.35e-84 | 1 | 126 | 0.9921 | 0.9921 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
FCJFCOMK_00180 | ARO:3003378 | 88.7 | 1.92e-88 | 21 | 162 | 0.8712 | 0.9861 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic target alteration |
Gene Name | phi_molconn_id | host gene_name | identity | evalue | qstart | qend | query_coverage | subject_coverage | host_descripton | disease_name | function | phenotype_of_mutant |
---|---|---|---|---|---|---|---|---|---|---|---|---|
FCJFCOMK_00002 | PHI:10113 | STM14_RS07770 (ttrA) | 70.6 | 0 | 1 | 1023 | 1.0000 | 1.0000 | eudicots | infection | tetrathionate reductase subunit A | reduced virulence |
FCJFCOMK_00053 | PHI:6982 | trg | 81.5 | 2.1e-222 | 5 | 535 | 0.9550 | 0.9815 | primates | salmonellosis | methyl-accepting chemotaxis protein | reduced virulence |
FCJFCOMK_00060 | PHI:10993 | mdoD | 85.5 | 2.1e-299 | 1 | 550 | 0.9982 | 0.9982 | rodents | infection | glucans biosynthesis protein D | unaffected pathogenicity |
FCJFCOMK_00076 | PHI:7225 | ydcR | 83.8 | 2.1e-231 | 1 | 469 | 0.9958 | 0.9873 | rodents | salmonellosis | putative transcriptional regulator | reduced virulence |
FCJFCOMK_00106 | PHI:10519 | narV | 81.4 | 3.7e-109 | 1 | 226 | 1.0000 | 1.0000 | rodents | urinary tract infection | respiratory nitrate reductase 2 gamma chain | reduced virulence |
FCJFCOMK_00107 | PHI:10518 | narW | 77.9 | 1.2e-102 | 1 | 231 | 1.0000 | 1.0000 | rodents | urinary tract infection | probable nitrate reductase molybdenum cofactor assembly chaperone | reduced virulence |
FCJFCOMK_00108 | PHI:10517 | narY | 90.7 | 1.6e-296 | 1 | 514 | 1.0000 | 1.0000 | rodents | urinary tract infection | respiratory nitrate reductase 2 beta chain | reduced virulence |
FCJFCOMK_00109 | PHI:10516 | narZ | 89.2 | 0 | 1 | 1246 | 1.0000 | 1.0000 | rodents | urinary tract infection | respiratory nitrate reductase 2 alpha chain | reduced virulence |
FCJFCOMK_00110 | PHI:123381 | narU | 84.3 | 1.1e-224 | 1 | 459 | 0.9935 | 0.9935 | rodents | salmonellosis | nitrate/nitrite transporter | unaffected pathogenicity |
FCJFCOMK_00117 | PHI:10997 | fdnG | 93.8 | 6.7e-107 | 1 | 195 | 1.0000 | 0.9833 | rodents | infection | formate dehydrogenase, nitrate-inducible, major subunit | unaffected pathogenicity |
FCJFCOMK_00118 | PHI:10997 | fdnG | 89.4 | 0 | 1 | 803 | 1.0000 | 0.9833 | rodents | infection | formate dehydrogenase, nitrate-inducible, major subunit | unaffected pathogenicity |
FCJFCOMK_00143 | PHI:8966 | mdtJ | 84.4 | 1.3e-47 | 1 | 122 | 1.0000 | 1.0000 | rodents | pneumonia | multidrug transporter subunit | reduced virulence |
FCJFCOMK_00144 | PHI:8967 | mdtI | 86.2 | 1.4e-48 | 1 | 109 | 1.0000 | 1.0000 | rodents | pneumonia | multidrug resistance protein | reduced virulence |
FCJFCOMK_00179 | PHI:5369 | MarA | 92.9 | 9.2e-65 | 1 | 126 | 0.9921 | 0.9921 | rodents | bacteremia | transcriptional regulator | reduced virulence |
Gene Name | cazy_id | identity | evalue | qstart | qend | query_coverage | subject_coverage |
---|---|---|---|---|---|---|---|
FCJFCOMK_00070 | QIU88825.1|CBM5|GH18 | 99.7 | 0 | 1 | 727 | 1 | 0.9973 |
FCJFCOMK_00171 | QIU88917.1|GH5_48 | 99.7 | 2.73e-309 | 1 | 395 | 1 | 1 |
FCJFCOMK_00198 | QMR38355.1|GH88 | 96.9 | 8.92e-291 | 1 | 388 | 1 | 1 |
FCJFCOMK_00217 | QIU88954.1|GH5_13 | 99.4 | 2.22e-280 | 1 | 362 | 1 | 1 |
Gene Name | tcid | identity | evalue | qstart | qend | query_coverage | subject_coverage | class_field | class_term | subclass | subclass_term | family | family_term |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FCJFCOMK_00006 | 2.A.76.1.5 | 77.4 | 9.3e-86 | 1 | 212 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.76 | The Resistance to Homoserine/Threonine (RhtB) Family |
FCJFCOMK_00007 | 9.B.121.4.1 | 70.5 | 0 | 1 | 878 | 1.0000 | 0.9989 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.121 | The AsmA (AsmA) Family |
FCJFCOMK_00033 | 1.E.53.1.6 | 72 | 1.9e-13 | 1 | 50 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.E | Holins | 1.E.53 | The Toxic Hok/Gef Protein (Hok/Gef) Family |
FCJFCOMK_00077 | 3.A.1.11.9 | 90.3 | 5.5e-214 | 1 | 381 | 1.0000 | 1.1306 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
FCJFCOMK_00078 | 3.A.1.11.9 | 84.1 | 9.7e-162 | 1 | 333 | 0.9881 | 0.9881 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
FCJFCOMK_00079 | 3.A.1.11.9 | 87.9 | 1.9e-151 | 3 | 313 | 0.9936 | 0.9288 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
FCJFCOMK_00080 | 3.A.1.11.9 | 92 | 9.8e-133 | 1 | 261 | 0.9739 | 0.7745 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
FCJFCOMK_00090 | 2.A.7.21.2 | 82.6 | 9.5e-61 | 1 | 149 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
FCJFCOMK_00095 | 1.B.14.9.5 | 78.9 | 0 | 1 | 703 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.14 | The Outer Membrane Receptor (OMR) Family |
FCJFCOMK_00100 | 2.A.3.1.8 | 92.5 | 2e-256 | 1 | 480 | 0.9938 | 0.9658 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.3 | The Amino Acid-Polyamine-Organocation (APC) Family |
FCJFCOMK_00109 | 5.A.3.1.2 | 89.2 | 0 | 1 | 1246 | 1.0000 | 1.0000 | 5 | Transmembrane Electron Carriers | 5.A | Transmembrane 2-electron transfer carriers | 5.A.3 | The Prokaryotic Molybdopterin-containing Oxidoreductase (PMO) Family |
FCJFCOMK_00110 | 2.A.1.8.10 | 83.3 | 5.5e-224 | 1 | 462 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
FCJFCOMK_00112 | 2.A.1.3.14 | 75.9 | 5.4e-193 | 1 | 494 | 0.9940 | 0.9980 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
FCJFCOMK_00116 | 2.A.7.17.2 | 77.7 | 2.6e-120 | 1 | 274 | 1.0000 | 0.9352 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
FCJFCOMK_00118 | 5.A.3.2.1 | 89.4 | 0 | 1 | 803 | 1.0000 | 0.7911 | 5 | Transmembrane Electron Carriers | 5.A | Transmembrane 2-electron transfer carriers | 5.A.3 | The Prokaryotic Molybdopterin-containing Oxidoreductase (PMO) Family |
FCJFCOMK_00142 | 2.A.86.1.4 | 76.4 | 1e-134 | 1 | 343 | 1.0000 | 0.9971 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.86 | The Autoinducer-2 Exporter (AI-2E) Family (Formerly the PerM Family, TC #9.B.22) |
FCJFCOMK_00143 | 2.A.7.1.9 | 82.9 | 1.6e-42 | 3 | 113 | 0.9098 | 0.9174 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
FCJFCOMK_00144 | 2.A.7.1.9 | 84.4 | 9.8e-47 | 1 | 109 | 1.0000 | 0.9008 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
FCJFCOMK_00151 | 2.A.1.36.1 | 87.7 | 1.7e-203 | 1 | 416 | 0.9905 | 0.9976 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
FCJFCOMK_00155 | 2.A.49.5.4 | 78.2 | 5.5e-178 | 13 | 429 | 0.9675 | 0.9976 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.49 | The Chloride Carrier/Channel (ClC) Family |
FCJFCOMK_00157 | 5.A.3.3.1 | 84 | 0 | 1 | 808 | 0.9988 | 1.0012 | 5 | Transmembrane Electron Carriers | 5.A | Transmembrane 2-electron transfer carriers | 5.A.3 | The Prokaryotic Molybdopterin-containing Oxidoreductase (PMO) Family |
FCJFCOMK_00162 | 2.A.7.26.1 | 83.2 | 1.3e-46 | 1 | 107 | 0.9907 | 0.9907 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
FCJFCOMK_00165 | 2.A.1.6.9 | 82.2 | 1.4e-190 | 29 | 444 | 0.9083 | 0.9649 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
FCJFCOMK_00176 | 2.A.1.2.55 | 71.9 | 1.8e-159 | 1 | 388 | 0.9798 | 0.9823 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
FCJFCOMK_00177 | 2.A.7.3.2 | 80.1 | 4.6e-131 | 1 | 297 | 0.9933 | 0.9933 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
FCJFCOMK_00181 | 2.A.95.1.1 | 89.1 | 1.1e-102 | 1 | 221 | 0.9955 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.95 | The 6 TMS Neutral Amino Acid Transporter (NAAT) Family |
FCJFCOMK_00182 | 2.A.1.2.15 | 83.1 | 6.7e-178 | 1 | 396 | 0.9950 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
FCJFCOMK_00205 | 1.A.46.2.6 | 77.9 | 5e-136 | 6 | 313 | 0.9840 | 0.9595 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.46 | The Anion Channel-forming Bestrophin (Bestrophin) Family |